AXGN

Axogen, Inc. Common Stock

$35.14

Current Price

All

AI analysis

Read what the AI thinks of Axogen, Inc. Common Stock in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

-$0.68

P/E

—

Data as of Oct 1

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

Expected EPS: $0.14

Nov 10

Posts

No posts about AXGN yet.

About Axogen, Inc. Common Stock

Axogen makes products that help surgeons repair damaged nerves, mostly after injuries or surgery. Its main products include a processed human nerve graft called Avance, plus connectors and wraps that protect nerves while they heal. The company sells directly to hospitals and surgeons and earns money each time its products are used in a procedure.